InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
60%
T+90 mean return
+0.9%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by GOLDSTEIN JOSEPH L, Director. Officer active across 1 company, notably Regeneron Pharmaceuticals, INC.. In total, 12 disclosures have been recorded. Activity tracked since 7 June 2021. The latest transaction was filed on 2 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
166 shares0Common StockSEC:0001968202-25-000004:0
2,707 shares@ US$625.6023.0% of flowCommon StockSEC:0001968202-24-000042:0
135 shares0Common StockSEC:0001968202-24-000023:0
3,613 shares@ US$482.6823.9% of flowCommon StockSEC:0001883850-23-000046:0
165 shares0Common StockSEC:0001883850-23-000018:0
2,431 shares@ US$374.120.0011% mcap22.7% of flowCommon StockSEC:0001883850-22-000032:0
191 shares0Common StockSEC:0001708138-22-000006
191 shares0Common StockSEC:0001708138-22-000006:0
2,479 shares@ US$380.950.0011% mcap22.2% of flowCommon StockSEC:0001708138-21-000076:0
2,479 shares@ US$380.9511.8% of flowCommon StockSEC:0001708138-21-000076
1,930 shares@ US$374.120.0008% mcap16.5% of flowCommon StockSEC:0001237899-21-000008:0
1,930 shares@ US$374.128.7% of flowCommon StockSEC:0001237899-21-000008
12 of 12 declarations
About GOLDSTEIN JOSEPH L
Joseph L. Goldstein serves as a Director at REGENERON PHARMACEUTICALS, INC. In this role, he contributes to the governance of the company and oversight of its operations. Goldstein plays a key role in developing the strategies and policies that guide the company in the pharmaceutical sector, ensuring that shareholder interests are protected.
